Attitudes of clinicians about screening head and neck cancer survivors for lung cancer using low-dose computed tomography
Annals of Otology, Rhinology & Laryngology Aug 22, 2019
Dukes K, Seaman AT, Hoffman RM, et al. - Researchers studied the practices and attitudes of clinicians towards lung cancer screening (LCS) with low-dose computed tomography (LDCT) in patients who survived head and neck cancer (HNC), using decision aids in the context of mandated shared decision-making (SDM) requirements. According to this qualitative study, clinicians acknowledged the usefulness of LCS with smoking history for some HNC survivors. In various clinical settings, however, they identified many challenges to SDM, including time, workflow, uncertainty about guidelines and reimbursement, decision aids, competing patient priorities, unclear evidence, potentially increased patient receptivity and stress, and the complexity of discussions. In addition, they identified challenges to LCS implementation. While clinicians feel that LDCT LCS may benefit some HNC survivors, both the implementation of LCS SDM in primary care for these patients as currently recommended and their integration into cancer clinics are barriers. SDM challenges across settings include the lack of decision-making aids tailored to cancer history patients. Given the recommendations for extending the eligibility criteria for LCS, more research may be needed before the current guidelines are refined.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries